You have 9 free searches left this month | for more free features.

provenge

Showing 1 - 25 of 39

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T Injection
  • (no location specified)
Nov 10, 2023

Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)

Recruiting
  • Prostate Cancer
  • Metastatic Prostate Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Feb 21, 2023

Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • New Haven, Connecticut
    Yale Cancer Center
Oct 20, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T
  • Oklahoma City, Oklahoma
    Stephenson's Cancer Center
Mar 28, 2023

Prostate Cancer Trial in Madison (sipuleucel-T, DNA Vaccine)

Completed
  • Prostate Cancer
  • sipuleucel-T
  • DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jun 15, 2021

Metastatic Castrate-resistant Prostate Cancer, mCRPC Trial in Dallas (Sipuleucel-T, Stereotactic Ablative Body Radiation)

Completed
  • Metastatic Castrate-resistant Prostate Cancer
  • mCRPC
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Apr 11, 2022

Metastatic Castrate-Resistant Prostate Cancer Treated With

Completed
  • Prostate Cancer
  • Durham, North Carolina
    Duke University Medical Center
Dec 22, 2020

Prostate Cancer Trial in San Francisco, Houston (SipT Treatment, Ipilimumab)

Completed
  • Prostate Cancer
  • San Francisco, California
  • +1 more
Jul 19, 2021

Prostate Cancer Trial in United States (Radium-223, Sipuleucel-T)

Completed
  • Prostate Cancer
  • Los Angeles, California
  • +4 more
Jun 15, 2021

Metastatic Prostate Cancer Trial in United States (Indoximod, Sipuleucel-T, Placebo)

Completed
  • Metastatic Prostate Cancer
  • Indoximod
  • +2 more
  • Chicago, Illinois
  • +3 more
Mar 20, 2020

Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer Trial in Duarte, Pasadena, Salt Lake City

Completed
  • Adenocarcinoma of the Prostate
  • +5 more
  • sipuleucel-T
  • +2 more
  • Duarte, California
  • +2 more
Aug 21, 2020

Prostate Cancer Trial in Durham (Sipuleucel-T, Lymph Node Biopsy)

Completed
  • Prostate Cancer
  • Durham, North Carolina
    Duke University Medical Center
Mar 30, 2020

Prostatic Tumors Trial in Augusta (CT-011 (Anti-PD1 Antibody), Sipuleucel-T (Provenge), Cyclophosphamide)

Terminated
  • Prostatic Neoplasms
  • CT-011 (Anti-PD1 Antibody)
  • +2 more
  • Augusta, Georgia
    Georgia Regents University
Jun 18, 2019

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in United States

Completed
  • Castration Levels of Testosterone
  • +3 more
  • Glycosylated Recombinant Human Interleukin-7
  • Laboratory Biomarker Analysis
  • La Jolla, California
  • +15 more
Jun 25, 2019

Enrolling Advanced Prostate Cancer Who Are to Receive

Completed
  • Castrate Refractory Metastatic Prostate Cancer (mCRPC)
  • Provenge
  • Scottsdale, Arizona
    21st Century Oncology
Jan 8, 2019

Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Terminated
  • Prostate Cancer
  • Sipuleucel-T
  • Scottsdale, Arizona
  • +38 more
Jul 16, 2019

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Nivolumab)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Apr 21, 2022

Prostate Cancer Metastatic, Hormone Refractory Prostate Cancer, Castration-resistant Prostate Cancer Trial in United States

Completed
  • Prostate Cancer Metastatic
  • +2 more
  • sipuleucel-T
  • abiraterone acetate
  • La Jolla, California
  • +20 more
Mar 5, 2019

Prostate Cancer Trial in Houston (Docetaxel, Sipuleucel-T)

Withdrawn
  • Prostate Cancer
  • Houston, Texas
    UTHealth Memorial Hermann Cancer Center
Oct 26, 2017

Prostate Cancer Trial in Houston (Sipuleucel-T, Docetaxel)

Withdrawn
  • Prostate Cancer
  • Houston, Texas
    UTHealth Memorial Hermann Cancer Center
Oct 26, 2017

Prostate Cancer Trial in United States (Control, Sipuleucel-T)

Completed
  • Prostate Cancer
  • Control
  • Sipuleucel-T
  • Berkeley, California
  • +17 more
Jun 29, 2017

Metastatic Prostate Cancer Trial in United States (sipuleucel-T, enzalutamide)

Completed
  • Metastatic Prostate Cancer
  • Tucson, Arizona
  • +18 more
Sep 25, 2018

CTC Immune Checkpoint

Completed
  • Prostate Cancer
  • CTC biomarker expression prevalence
  • Durham, North Carolina
    Duke University Medical Center
Jul 8, 2019

Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Completed
  • Advanced Prostate Cancer
  • Prostatic Neoplasms
  • sipuleucel-T
  • Bessemer, Alabama
  • +332 more
Mar 5, 2019

Prostate Cancer, Castrate Resistant Prostate Cancer Trial in Marina del Rey (sipuleucel-T, ipilimumab)

Completed
  • Prostate Cancer
  • Castrate Resistant Prostate Cancer
  • Marina del Rey, California
    Prostate Oncology Specialists, Inc.
Aug 23, 2017